Dean L. Schorno

Dean L. Schorno

atRigel Pharmaceuticals· In proxies 2021–2025

Pay in FY2022-1% from the year before · Rigel Pharmaceuticals stock -43.4% the same year

Dean L. Schorno was paid $1.1M in FY2022 (Dec), down 1%. Rigel Pharmaceuticals stock fell 43.4% that year.

Pay$100 in the stock at the end of FY20 → $43
Pay is from the Summary Compensation Table of each Rigel Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rigel PharmaceuticalsPublic company · 5 yr
    • 2021 – Present · 5 yrStock in role +38%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?